Literature DB >> 17093102

Binding of glucuronoxylomannan to the CD14 receptor in human A549 alveolar cells induces interleukin-8 production.

Fabiane M Barbosa1, Fernanda L Fonseca, Rodrigo T Figueiredo, Marcelo T Bozza, Arturo Casadevall, Leonardo Nimrichter, Marcio L Rodrigues.   

Abstract

Glucuronoxylomannan (GXM) is the major capsular polysaccharide of Cryptococcus neoformans. GXM receptors have been characterized in phagocytes and endothelial cells, but epithelial molecules recognizing the polysaccharide remain unknown. In the current study, we demonstrate that GXM binds to the CD14 receptor in human type II alveolar epithelial cells, resulting in the production of the proinflammatory chemokine interleukin-8.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17093102      PMCID： PMC1797707          DOI： 10.1128/CVI.00296-06

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN： 1556-679X


  26 in total

Review 1.  Innate immunity in the lung: how epithelial cells fight against respiratory pathogens.

Authors:  R Bals; P S Hiemstra
Journal:  Eur Respir J       Date:  2004-02       Impact factor: 16.671

Review 2.  Time to abandon dogma: CD14 is expressed by non-myeloid lineage cells.

Authors:  Hubertus P A Jersmann
Journal:  Immunol Cell Biol       Date:  2005-10       Impact factor: 5.126

3.  Modulation of human beta-defensin-2 transcription in pulmonary epithelial cells by lipopolysaccharide-stimulated mononuclear phagocytes via proinflammatory cytokine production.

Authors:  Yuko Tsutsumi-Ishii; Isao Nagaoka
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

4.  Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis.

Authors:  Robert A Larsen; Peter G Pappas; John Perfect; Judith A Aberg; Arturo Casadevall; Gretchen A Cloud; Robert James; Scott Filler; William E Dismukes
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

5.  Immunology of infection caused by Cryptococcus neoformans.

Authors:  Floyd L Wormley; John R Perfect
Journal:  Methods Mol Med       Date:  2005

6.  IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis.

Authors:  Asna A Siddiqui; Annemarie E Brouwer; Vannaporn Wuthiekanun; Shabbar Jaffar; Robin Shattock; Diane Irving; Joanna Sheldon; Wirongrong Chierakul; Sharon Peacock; Nicholas Day; Nicholas J White; Thomas S Harrison
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

7.  Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures.

Authors:  Stefan Oscarson; Mia Alpe; Pär Svahnberg; Antonio Nakouzi; Arturo Casadevall
Journal:  Vaccine       Date:  2005-03-24       Impact factor: 3.641

8.  Cryptococcus neoformans capsular glucuronoxylomannan induces expression of fas ligand in macrophages.

Authors:  Claudia Monari; Eva Pericolini; Giovanni Bistoni; Arturo Casadevall; Thomas R Kozel; Anna Vecchiarelli
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

9.  Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo.

Authors:  Lauren E Yauch; Michael K Mansour; Shmuel Shoham; James B Rottman; Stuart M Levitz
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Local antilaminin antibody treatment alters the rejection pattern of murine cardiac allografts: correlation between cellular infiltration and extracellular matrix.

Authors:  Ingo Riederer; Suse D Silva-Barbosa; Marcio L Rodrigues; Wilson Savino
Journal:  Transplantation       Date:  2002-12-15       Impact factor: 4.939
View more
  20 in total

1.  Capsular Material of Cryptococcus neoformans: Virulence and Much More.

Authors:  A Vecchiarelli; C Monari
Journal:  Mycopathologia       Date:  2012-02-08       Impact factor: 2.574

Review 2.  Host cell invasion by medically important fungi.

Authors:  Donald C Sheppard; Scott G Filler
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 3.  Can host receptors for fungi be targeted for treatment of fungal infections?

Authors:  Scott G Filler
Journal:  Trends Microbiol       Date:  2013-06-21       Impact factor: 17.079

4.  Glucuronoxylomannan from Cryptococcus neoformans down-regulates the enzyme 6-phosphofructo-1-kinase of macrophages.

Authors:  Juliana Grechi; Monica Marinho-Carvalho; Patricia Zancan; Leonardo Paes Cinelli; Andre M O Gomes; Marcio L Rodrigues; Leonardo Nimrichter; Mauro Sola-Penna
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

5.  TLR4 recognizes Pseudallescheria boydii conidia and purified rhamnomannans.

Authors:  Rodrigo T Figueiredo; Patrícia L Fernandez; Fabianno F Dutra; Yissett González; Lívia Cristina Lopes; Vera Carolina B Bittencourt; Guilherme L Sassaki; Eliana Barreto-Bergter; Marcelo T Bozza
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

6.  Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct.

Authors:  Priscila C Albuquerque; Fernanda L Fonseca; Fabianno F Dutra; Marcelo T Bozza; Susana Frases; Arturo Casadevall; Marcio L Rodrigues
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 7.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

8.  The still obscure attributes of cryptococcal glucuronoxylomannan.

Authors:  Marcio L Rodrigues; Fernanda L Fonseca; Susana Frases; Arturo Casadevall; Leonardo Nimrichter
Journal:  Med Mycol       Date:  2009-12       Impact factor: 4.076

9.  The elastic properties of the Cryptococcus neoformans capsule.

Authors:  Susana Frases; Bruno Pontes; Leonardo Nimrichter; Marcio L Rodrigues; Nathan B Viana; Arturo Casadevall
Journal:  Biophys J       Date:  2009-08-19       Impact factor: 4.033

10.  Aimless mutants of Cryptococcus neoformans: failure to disseminate.

Authors:  E J Griffiths; M Kretschmer; J W Kronstad
Journal:  Fungal Biol Rev       Date:  2012-03-30       Impact factor: 4.706
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.